Question 78

The prescription appears to contain a look-alike/sound-alike error.

The technician should alert the pharmacist because the prescribed medication, levetiracetam, is typically used as an anticonvulsant rather than for pneumonia, which suggests a possible error in the prescription.

A) the prescription appears to contain a look-alike/sound-alike error.

This option is correct as levetiracetam is not indicated for pneumonia, and its name could easily be confused with other medications that are used to treat respiratory conditions. The technician's responsibility includes identifying such discrepancies to ensure patient safety.

B) levetiracetam requires special handling.

This option is incorrect. Levetiracetam does not require any special handling procedures that would necessitate alerting the pharmacist in this context. It is a standard medication that can be dispensed without additional precautions.

C) the prescription exceeds the maximum recommended daily dose.

This option is incorrect. The prescribed dose of 500 mg once daily is within the recommended dosing guidelines for levetiracetam, which typically allows for much higher daily doses depending on the clinical condition being treated.

D) levetiracetam is subject to a REMS program.

This option is incorrect. Levetiracetam is not classified under any REMS (Risk Evaluation and Mitigation Strategies) program, as it does not have significant risks that require such monitoring. Therefore, there is no need to alert the pharmacist regarding REMS for this medication.

Conclusion

The correct answer highlights a critical oversight in the prescription that could pose a risk to the patient due to the misuse of levetiracetam for treating pneumonia. All other options do not accurately reflect the situation, as they either misinterpret the drug's handling requirements or dosing guidelines. Identifying look-alike/sound-alike errors is essential to prevent medication errors and ensure patient safety.